glutathione pharmaceuticvals (L) REDUCED EP (PHARMA GRADE) Glutathione Supplementation: The Antioxidant Your

Qian W, Wang L, Li P, Hu Y, Wang Q, Yi K, Wu M, Xu Y, Song J, Chen P, Zhang H, Ma J, Xie Y (2020) Efficiency and tolerability of induction and consolidation therapy with arsenic trioxide/bortezomib/ascorbic acid/dexamethasone (ABCD) regimen compared to bortezomib/dexamethasone (BD) regimen in newly diagnosed myeloma patients

& Attia, A

119 A promising drug target should exhibit a well-defined causal relationship with the onset, progression, or pathophysiological processes of the disease, and its modulation should effectively alleviate symptoms or slow disease progression

[,] However, an RCT conducted in Denmark evaluated the consequences associated with additional NAC for a 24-week period in 80 people with bipolar disease did not support the findings